Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangying Hu

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort studyXingmei Yao, Wen Chen, Chao Zhao, et al.
The Lancet Regional Health. Western Pacific|September 2, 2025
Long-term efficacy and immunopersistence of an <i>Escherichia coli</i>-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohortFanghui Zhao, Qi Chen, Chao Zhao, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort studyXingmei Yao, Wen Chen, Chao Zhao, et al.
The Lancet Regional Health. Western Pacific|September 2, 2025
Long-term efficacy and immunopersistence of an <i>Escherichia coli</i>-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohortFanghui Zhao, Qi Chen, Chao Zhao, et al.
Pageof 7